2022-2028 Pain Management Devices Industry Analysis & Professional Market Research Report, Analysis From Perspective Of Segmentation

According to the latest study on ‘Pain Management Devices Market to 2027 – Covid-19 Impact and Global Analysis and Forecast by Product Type and Application,’ the market is expected to reach US$ 8,388.67 million in 2027 from US$ 4,527.31 million and in 2019. The market is estimated to grow at a CAGR of 8.1% from 2020 to 2027. The report provides trends prevailing in the global pain management devices market and the factors driving market along with those that act as hindrances.

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis –

https://www.theinsightpartners.com/sample/TIPHE100000860/

The key factors that are driving growth of the pain management devices market are increasing chronic pain incidences, rising product launches, and growing geriatric population. Moreover, technological advancements in pain management devices are likely to have positive impact on the market. However, the lack of awareness regarding pain management and high cost of pain management devices are likely to restrict the market growth.

Medtronic plc, ST. Jude Medical, Inc., Boston Scientific Corporation, Hospira, Inc., Halyard Health, Inc, Smiths Medical, B. Braun Melsungen AG, Neurotech NA, Inc., BD, and Nevro Corp. are among the leading companies operating in the pain management devices market.   

Based on the type, the global pain management devices market is segmented into neuromodulation devices, ablation devices, and analgesic infusion pumps. The neuromodulation devices segment held the largest share of the market in 2019; however, the ablation devices segment is estimated to register the highest CAGR in the market during the forecast period. Growing demand for minimally invasive surgeries and product developments by the market players are likely to enhance the market growth of the segment during the forecast period. In February 2019, Medtronic received FDA approval and launched its Accurian radiofrequency ablation system for treatment of chronic pain in the US. Based on application, the pain management devices market is segmented into neuropathic pain, cancer pain, facial pain and migraine, musculoskeletal pain, and others.

Click here to avail lucrative discounts on our latest reports. We offer student, enterprise, and special periodic discounts to our clientele. Please fill the inquiry form below to know more -

https://www.theinsightpartners.com/discount/TIPHE100000860/

The Report Segments Global Pain Management Devices Market as Follows:

By Product Type

Neuromodulation DevicesTranscutaneous Electrical Nerve Stimulation (TENS) DevicesSpinal Cord Stimulation (SCS) DevicesAblation DevicesRadiofrequency Ablation DevicesCryoablation DevicesAnalgesic Infusion PumpsIntrathecal Infusion PumpsExternal Infusion Pumps

By Application

Neuropathic PainCancer PainFacial Pain and MigraineMusculoskeletal PainOthers

By Geography

North AmericaUSCanadaMexicoEuropeFranceGermanyUKSpainItalyAsia Pacific (APAC)ChinaIndiaJapanAustraliaSouth KoreaMiddle East and Africa (MEA)Saudi ArabiaUAESouth AfricaSouth and Central America (SCAM)BrazilArgentina

Immediate delivery of our off-the-shelf reports and prebooking of upcoming studies, through flexible and convenient payment methods –

https://www.theinsightpartners.com/buy/TIPHE100000860/

 About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense, Food & beverage, Chemical and Materials, Semiconductors etc.

 

Contact Us:

Call: +1-646-491-9876

Email: [email protected]

0